Skip to main content

Home Infusion Therapy Market to Exhibit 2.2% CAGR and Reach USD 86.89 Billion by 2027; Rising Prevalence of COVID19 Pandemic to Promote Growth, says Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, Sept. 14, 2020 (GLOBE NEWSWIRE) — The home infusion therapy market size was USD 27.25 billion in 2019 and is expected to grow at a CAGR of 2.2% and reach USD 86.89 billion by 2027.In a home infusion therapy setting, a patient receives all medical assistance at home including drugs and biologics via a subcutaneous or an intravenous administrative route. According to a recent report by Fortune Business Insights titled, “Home Infusion Therapy Market Size, Share & Covid-19 Impact Analysis, By Product (Devices, Drugs, and Services) By Indication (Anti-Infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Total Parenteral Nutrition, Immunoglobulin Therapy, and Others), and Regional Forecast, 2020-2027,”.The Report Answers the Following QueriesWhat is the nature of the market and how fierce is its competition?What are the key industry insights to the market?What strategies are adopted by players to gain momentum in the market?How is the COVID19 pandemic helping the market to grow?
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/home-infusion-therapy-market-102989
Drivers & Restraints-Lockdowns Amid COVID-19 Pandemic to Bode Well for the MarketThe increasing prevalence of the geriatric population and their vulnerability towards chronic diseases such as cancer, diabetes, and cardiac issues among others stands as major home infusion therapy market devices. In addition to this, the increasing cases of hospital-acquired infections are also propelling people to opt for medical services at home. This, coupled with cost-efficient home treatment faster recovery at home than hospitals are likely to bode well for the market.On the flip side, most of the developing nations lack reimbursement structure and policy for home treatment which ultimately increases the out-of-pocket expenditure. This, coupled with a lack of proper medical assistance and limited sources in a home setting, may cause hindrance to the market. Nevertheless, the increasing number of innovations in the medical sector and the advent of devices such as portable infusion pumps, and others are likely to create lucrative growth opportunities for the market. Furthermore, the current pandemic of coronavirus that propelled people to stay at home is projected to promote the home infusion therapy market growth.The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.We are making continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/home-infusion-therapy-market-102989
Regional Analysis-North America to Dominate Market on Account of Rising Adoption of Innovative TechnologiesRegionally, North America emerged at the top with a revenue of USD 10.53 billion in 2019. The growth of this region is attributable to the development of delivery devices for home medication and its increasing adoption. Besides this, the rising number of patients and rapid adoption of the latest technologies are factors responsible for the dominance of this region.Besides this, the Asia Pacific market is anticipated to witness rapid growth in the forecast duration on account of the increasing prevalence of diabetes, heart issues, cancer, and other long-lasting diseases in the region.Competitive Landscape-Handful of Vendors Covering Majority Shares Attributed to Massive Investment on Innovative DevicesThe global home infusion therapy market is dominated by a handful of companies thereby depicting a consolidated nature of the market. These include Option Care Health Inc., Optum Inc., Melsungen AG, and Braun. The dominance of these players is accountable for the expansion of geographical footprint, major investments in the development of innovative devices, and infusion pumps.
Quick Buy –  Home Infusion Therapy Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102989
Notable Industry Developments of this market include:July 2019 – Food and Drug Administration approved the first and ready-to-use insulin called Myxredlin manufactured by Baxter.December 2019 – Diplomat and Optum Inc. entered into a partnership for specialty infusion and pharmaceutical services in the U.S. The key objective behind this merger strategy is to serve patients with chronic diseases with therapeutic measures such as oncology and immunology in the entire U.S.
Fortune Business Insights™ lists out the names of market manufacturers. They are as follows:Optum, Inc.InfusystemOption Care Health Inc.Moog Inc.CareCentrix, Inc.B. Braun Melsungen AGLincare Holdings Inc.BaxterPromptcareBriovaRx Infusion ServicesOther players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/home-infusion-therapy-market-102989
Home Infusion Therapy Market Segmentations:By Product•              Devices•              Drugs•              ServicesBy Indication•              Anti-Infectives•              Chemotherapy•              Hydration Therapy•              Enteral Nutrition•              Total Parenteral Nutrition•              Immunoglobulin Therapy•              OthersBy Geography•              North America (the U.S. and Canada)•              Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)•              Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)•              The Rest of the World
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/home-infusion-therapy-market-102989
Have a Look at Related Reports:Bone Graft Substitutes Market Share & Industry Analysis, By Type (Autograft, Allograft, Demineralized bone matrix (DBM), Synthetic, Xenograft), By Application (Spinal Fusion, Joint Reconstruction, Foot & Ankle, Others), By End User (Hospitals, Specialty Clinics) and Regional Forecast, 2020-2027Telerehabilitation Market Share and Covid-19 Impact Analysis, By Type (Products, Services), By Application (Occupational Therapy, Physical Therapy, Chronic Diseases, and Others), By End-User (Healthcare Facilities and Homecare); and Regional Forecast, 2020-2027Ventilator Market Share & Covid-19 Impact Analysis, By Type (Adult, and Paediatric & Neonatal), By Interface (Invasive, and Non-invasive), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2020-2027C-arms Market Share & Industry Analysis, By Type (Fixed, Mobile), By Application (Or-thopedics and Trauma, Cardiology, Neurology, Gastroenterology, Oncology, and Others), By Detector (Flat Panel Detector, and Image Intensifier), By End User (Hospitals, Diagnostic Centers, Clinics and Others) and Regional Forecast, 2020-2027Cancer Cachexia Market Share & Covid-19 Impact Analysis, By Product (Progestogens, Corticosteroids, Combination Therapies, and Others), By Distributional Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027
About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/home-infusion-therapy-market-10021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.